When exploring the structural biology of the EGFR peptide sequence, one quickly realizes that this field is a fascinating intersection of computational design and protein chemistry. As an enthusiast who studies peptide interactions, I have found that understanding the nuances of the EGFR (Epidermal Growth Factor Receptor) structure is essential for anyone interested in how these amino acid chains function within complex biological systems.
The Canonical Sequence and Structural Architecture
The EGFR_HUMAN protein, also known as ErbB-1 or HER1, is a massive transmembrane protein consisting of 1,210 am EGFR Gene - Epidermal Growth Factor Receptor ino acids. When looking at the isoform 1 (p170) is the canonical sequence of EGFR, it is clear why it remains a central subject of study. This receptor is a member of the epidermal growth factor receptor (HER) family, which includes Her-2/ErbB-2, Her-3, and Her-4.
From a technical standpoint, the EGFR kinase domain can be activated by increasing its local concentration, a phenomenon that highlights the importance of spatial orientation. Researchers often utilize specific fragments, such as the amino acid peptide fragment derived from positions 985-996, to map out binding affinities.
Innovations in Peptide Targeting
The development of specialized ligands has rev Epidermal Growth Factor ReceptorPeptide(985-996) is anamino acid peptidefragment derived from positions 985-996 in epidermal growth factor receptor (EGFR).Read more olutionized how we view these receptors. For instance, EGFR-targeting peptides were developed by different groups using diverse methodologies. One of the most frequently cited examples is Peptide 1 (or GE11, Table 1), a dodecapeptide known for its specific binding capability. Unlike some other ligands, the EGFR-binding peptide GE11 is particularly interesting because it demonstrates how a peptide can be engineered for precision without necessarily triggering the standard activation pathways.
Furthermore, recent advancements have introduced EGFRp1 and EGFRp4 peptides, which were identified through ribosome displ EGFR structure ay techniques. These 11-mer sequences sho Catalog Number: P001613. Sequence:Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Lys. Synonym: EGFR-derived peptide. Molecular Weight: 1579.78 Read more wcase the potential for high-affinity binding against the extracellular domain of the receptor.
Practical Data and Sequences
When analyzing the Homo sapiens epidermal growth factor receptor mRNA data, one encounters specific sequences that define the receptor's function. I have often referenced the Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Lys sequence, which is a well-documented EGFR-derived peptide with a molecular weight of approximately 1579.78 Da.
The complexity of these interactions is further illustrated by the EGFR ligands epiregulin (EREG) and epigen (EPGN), which stabilize unique dimeric conformations. It is a fundamental truth that EGFR is a ce Epidermal Growth Factor Receptor Peptide (985-996) ll surface protein that binds to epidermal growth factor, and the amino acid sequences involved in these interfaces determine the stability and efficacy of the resulting complex.
Final Thoughts on Research Methodology
Whether you are reviewing the sequence of a novel synthetic ligand or analyzing the EGFR kinase domain, the precision of the amino acid com by H Hossein-Nejad-Ariani·2019·Cited by 130—Peptide 1 (or GE11, Table 1) is a dodecapeptide that binds specifically to epidermal growth factor receptor (EGFR or ErbB1) overexpressed in a Read more position is paramount. The study of these receptors continues to evolve as new peptide designs emerge. By focusing on the structural biology and the specific binding motifs, we gain a deeper appreciation for the intricate design of the EGFR system.
It is always rewarding to see how researchers refine these amino acid sequences to achieve better selectivity, ensuring that the study of these proteins remains at the forefront of biochemical exploration.